These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3757917)

  • 1. Further data supporting episodic degenerative discharge of thyroid hormone from nodular goiters.
    Kodama T; Maeda M; Ito Y; Obara T; Fujimoto Y
    Endocrinol Jpn; 1986 Apr; 33(2):215-20. PubMed ID: 3757917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between T4, T3 and T4/T3 ratio in thyroid tissue, thyroid and peripheral veins in patients with nontoxic nodular goiter.
    Solter M; Tislarić D; Petric V; Pegan B
    Exp Clin Endocrinol; 1989; 94(3):305-12. PubMed ID: 2630310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum thyroglobulin levels during the TRH test in euthyroid female patients with diffuse and nodular goiters].
    Durica S; Milosević D; Sinadinović J
    Srp Arh Celok Lek; 1990; 118(9-10):361-6. PubMed ID: 2129364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid physiology and functional tests.
    Zellmann HE
    Major Probl Clin Surg; 1980; 15():70-84. PubMed ID: 6893732
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-toxic goiter treatment with 1-triiodothyronine and 1-thyroxine.
    FAWELL WN; CATZ B
    Calif Med; 1963 Apr; 98(4):197-9. PubMed ID: 13944597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The syndrome of tissue resistance to thyroid hormones].
    Linquette M
    Presse Med; 1987 Jun; 16(25):1234-8. PubMed ID: 2885829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
    Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.
    Dige-Petersen H; Clemmensen OJ; Hummer L
    Nuklearmedizin; 1976 Aug; 15(4):197-200. PubMed ID: 824625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of a sensitive TSH-RIA].
    Seidel C; Ziegelitz D; Weber A; Dittmer T; Gerl H; Knappe G; Correns HJ
    Endokrinologie; 1982 Oct; 80(2):181-93. PubMed ID: 6819129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anion gap with thyroid dysfunction and nodular goiter in CAPD patients.
    Lin CC; Yang WC; Ng YY; Chou YH; Tarng DC; Chen TW
    Perit Dial Int; 2002; 22(3):394-9. PubMed ID: 12227399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.
    Vermiglio F; Benvenga S; Melluso R; Catalfamo S; Princi P; Battiato S; Consolo F; Trimarchi F
    J Endocrinol Invest; 1986 Oct; 9(5):389-96. PubMed ID: 3098822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABNORMAL THYROIDAL METABOLISM IN TWO PATIENTS WITH NON-TOXIC NODULAR GOITERS.
    ROW VV; JOHNSTON MW; EZRIN C; VOLPE R
    Acta Endocrinol (Copenh); 1964 Aug; 46():665-74. PubMed ID: 14202482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
    Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial thyroid hormone resistance.
    Brooks MH; Barbato AL; Collins S; Garbincius J; Neidballa RG; Hoffman D
    Am J Med; 1981 Sep; 71(3):414-21. PubMed ID: 6792914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre- and postoperative thyroglobulin secretion into the blood in nodular goiter].
    Gemsenjäger E; Girard J; Martina B
    Schweiz Med Wochenschr; 1984 Jun; 114(23):826-9. PubMed ID: 6740300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
    Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
    Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral resistance to thyroid hormone in an infant.
    Kaplowitz PB; D'Ercole AJ; Utiger RD
    J Clin Endocrinol Metab; 1981 Nov; 53(5):958-63. PubMed ID: 6793616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.